Skip to content
Governance Register

← US public companies

Hookipa Pharma Inc.

SEC CIK 1760542 · HOOK · last insider filing 2025-10-09

Directors (from insider filings)

NameCapacity as filedFilings
Peters Malte Director · Chief Executive Officer filed 2023 - 2025
Coelho Mary Theresa Director · EVP and CFO filed 2023 - 2025
Cassidy Sean A Director filed 2024 - 2024
O'Neill Julie Director filed 2019 - 2024
van de Winkel Jan Director filed 2019 - 2024
Kaufman David Ross Director filed 2019 - 2024
Reilly Timothy P. Director filed 2022 - 2024
Aldag Jorn Director · Chief Executive Officer filed 2019 - 2024
Kandera Reinhard Director · Chief Financial Officer filed 2019 - 2024
Kelly Michael Aaron Director filed 2019 - 2022
Seghezzi Graziano Director filed 2019 - 2021
Lengauer Christoph Director filed 2019 - 2021
Soria Jean-Charles Director filed 2020 - 2021
van Deventer Sander Director filed 2019 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Orlinger Klaus Sr. VP, Research filed 2019 - 2024
Necina Roman Chief Technology Officer filed 2019 - 2024
Winderlich Mark Chief Development Officer filed 2024 - 2024
Baker Christine D. Chief Operating Officer filed 2021 - 2023
Schlienger Katia Chief Medical Officer filed 2023 - 2023
Matushansky Igor Chief Medical Officer filed 2019 - 2022
Lilja Anders Sr. VP, Technical Development filed 2019 - 2020
Pinschewer David Chief Scientific Officer filed 2019 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.